Elaprase

Elaprase is a medicine authorised by Swissmedic under authorisation number 57916. The authorisation holder is Takeda Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 20 March 2007 and the authorisation is valid without a time limit. ATC code A16AB09 places the medicine in the group Other alimentary tract and metabolism products.

Dispensing category A
Authorisation number 57916
ATC A16AB09
Biotechnological medicines

Authorisation data
Authorisation number	57916
Name	Elaprase
Full name	Elaprase, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holder	Takeda Pharma AG
Medicinal product code	Biotechnological medicines
Dispensing category	A · Prescription, not repeatable
ATC code	A16AB09
First authorisation	20 March 2007
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	Elaprase, Konzentrat zur Herstellung einer Infusionslösung	A	20 March 2007

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	1	Durchstechflasche(n)	A16AB09	07.14.0.	A

Scroll the table sideways

Other medicines from this authorisation holder

Adcetris 50 mgAuthorisation number 62132 · ATC L01FX05A Advate 250 IE (5 ml)Authorisation number 56352 · ATC B02BD02B Adynovi 250 IE (5 ml)Authorisation number 65953 · ATC B02BD02B Adzynma 500 I.E.Authorisation number 69562 · ATC B01AD13B Agopton 30 mgAuthorisation number 51969 · ATC A02BC03B Alunbrig 30 mgAuthorisation number 66738 · ATC L01ED04A Ceprotin 500 I.E.Authorisation number 56124 · ATC B01AD12B Cinryze 500 IEAuthorisation number 61636 · ATC B06AC01B

Frequently asked questions

Is Elaprase authorised in Switzerland?

Yes. Elaprase is authorised by Swissmedic under authorisation number 57916, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Elaprase have?

Elaprase is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Elaprase?

The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.